Chiara Massa Selected Research

Member 2 Subfamily B ATP Binding Cassette Transporter

8/2020	Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.
1/2020	Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiara Massa Research Topics

Disease

31	Neoplasms (Cancer) 04/2023 - 02/2004
6	Renal Cell Carcinoma (Grawitz Tumor) 04/2023 - 06/2011
6	Melanoma (Melanoma, Malignant) 04/2023 - 01/2020
6	Breast Neoplasms (Breast Cancer) 06/2022 - 11/2013
4	Disease Progression 01/2023 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2015
2	COVID-19 10/2023 - 11/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2020
2	Carcinogenesis 01/2020 - 08/2015
1	Triple Negative Breast Neoplasms 04/2024
1	Leukemia 04/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Human Influenza (Influenza) 11/2022
1	Microsatellite Instability 01/2022
1	Pathologic Complete Response 01/2022
1	Lung Neoplasms (Lung Cancer) 09/2021
1	Squamous Cell Carcinoma of Head and Neck 09/2020
1	Carcinoma (Carcinomatosis) 08/2015
1	Neoplasm Metastasis (Metastasis) 09/2005

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2004
5	InterferonsIBA 04/2023 - 01/2020
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2013
5	MicroRNAs (MicroRNA)IBA 11/2022 - 05/2016
5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
5	HLA Antigens (Human Leukocyte Antigens)IBA 08/2021 - 06/2011
4	Messenger RNA (mRNA)IBA 01/2022 - 08/2015
4	Peptides (Polypeptides)IBA 01/2020 - 02/2004
3	BiglycanIBA 01/2023 - 01/2018
3	HLA-G Antigens (HLA G)IBA 11/2022 - 06/2015
3	AntigensIBA 11/2022 - 02/2004
3	Hormones (Hormone)IBA 06/2022 - 01/2020
2	VaccinesIBA 10/2023 - 02/2004
2	Histocompatibility Antigens Class IIBA 01/2023 - 08/2020
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2022
2	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2023 - 01/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023 - 01/2023
2	Bovine Serum AlbuminIBA 01/2023 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2021
2	LigandsIBA 01/2022 - 06/2011
2	Member 2 Subfamily B ATP Binding Cassette TransporterIBA 08/2020 - 01/2020
2	Surface Antigens (Surface Antigen)IBA 08/2020 - 06/2011
2	AntibodiesIBA 10/2019 - 08/2015
2	EpitopesIBA 03/2017 - 02/2004
1	durvalumabIBA 04/2024
1	Immunoglobulin G (IgG)IBA 10/2023
1	Immunoglobulin A (IgA)IBA 10/2023
1	CytokinesIBA 04/2023
1	Caspase 1 (ICE Protease)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	Pattern Recognition ReceptorsIBA 01/2023
1	InterleukinsIBA 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2023
1	Proteoglycans (Proteoglycan)IBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Small Leucine-Rich ProteoglycansIBA 01/2023
1	purineIBA 01/2023
1	avelumabIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	NivolumabIBA 09/2021
1	Histocompatibility Antigens Class IIIBA 08/2021
1	Circulating Tumor DNAIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2020
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	ParaffinIBA 01/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2020
1	LuciferasesIBA 01/2020
1	Horseradish PeroxidaseIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Firefly LuciferasesIBA 01/2020
1	transporter associated with antigen processing (TAP)IBA 01/2020
1	tapasinIBA 01/2020
1	anthraceneIBA 01/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019
1	Extracellular Matrix ProteinsIBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2017
1	Conditioned Culture MediaIBA 12/2015
1	Transcription Factors (Transcription Factor)IBA 08/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2015
1	Small Interfering RNA (siRNA)IBA 08/2015
1	HLA-DR Antigens (HLA-DR)IBA 06/2015
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 11/2013
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2011
1	Therapeutic UsesIBA 09/2005
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2004

Therapy/Procedure

12	Immunotherapy 04/2023 - 02/2004
9	Therapeutics 01/2023 - 04/2013
1	Drug Therapy (Chemotherapy) 06/2022
1	Neoadjuvant Therapy 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2021
1	Transplantation 12/2013